FDA 483 - Koriand'r Williams, M.D. - December 22, 2021

Koriand'r Williams, M.D. in Houston, TX, a clinical investigator, was cited for significant deficiencies in conducting and supervising clinical investigations. The inspection revealed failures in ensuring accurate subject data, proper documentation of adverse findings, and adherence to investigational plans and standard operating procedures. These issues indicate a lack of oversight and proper record-keeping, potentially compromising study integrity.